Recently, we were excited to hear that Sanofi/AgaMatrix have received FDA clearance for the iBGStar , the first blood glucose monitor that connects directly to an Apple...

While the rest of America was watching the Super Bowl, we were taking in the countryside in Montpellier, France, at first annual European Diabetes Technology and...

On August 31, Abbott Diabetes Care announced that it will permanently discontinue the FreeStyle Navigator continuous glucose monitoring (CGM) system in the United States...

Tandem Diabetes Care recently announced that its much anticipated t:slim insulin pump had received FDA clearance. This new pump features a color touchscreen and sleek...

At EASD, Cellnovo announced that it had received approval in Europe for its new insulin patch pump. It will be launched soon in the UK, and its submission to the FDA is...

Self-monitoring of blood glucose (SMBG, i.e., fingersticks) and continuous glucose monitoring (CGM, i.e., wearing a sensor) sometimes seem like rival technologies in the...

Highlights from Maryland's back-to-back meetings.

Our trip to Berlin brought new insights on implantable GLP-1, the latest in CGM and the artificial pancreas, and debates on early insulin therapy.

The artificial pancreas in peoples’ homes at the Annual Technologies & Treatments for Diabetes Meeting in Paris.

In June 2012, Medtronic held an Investor Conference to describe its upcoming products and expectations for the next five years. One of the biggest news items for...

Ever wondered if we have it better or worse than other countries? Dr. Dorothee Deiss reveals the state of diabetes care in Germany.

Click to learn exciting news on the artificial pancreas, faster insulins, and the results of the much-anticipated ORIGIN trial.

On December 14, the FDA granted 510(k) clearance for Insulet’s next-generation, much smaller OmniPod insulin patch pump, concluding a lengthy 19-month US regulatory...

On July 13, Johnson & Johnson acquired Calibra Medical , maker of the Finesse “insulin patch-pen” for type 1 and type 2 diabetes. The slimly designed Finesse (2...

On November 28, CeQur announced that it had received CE Mark approval for its PaQ Insulin Delivery Device , allowing the product to be sold in Europe. The Swiss-based...

Over the course of their lifetimes, roughly half of all people with diabetes develop diabetic neuropathy, which affects the nerves and can cause feelings of numbness and...

On November 29, NeuroMetrix announced that it had cleared the final hurdle holding up the introduction of the Sensus Pain Management System, designed for the treatment...

Wireless, cell phone-enabled, and data-to-the-cloud glucose meters are a new trend in diabetes, evidenced by the recent launch of Sanofi’s iBGStar (see test drive in...

The 2012 Diabetes Technology Meeting provides new insights into the artificial pancreas and the latest thinking on regulation from the FDA.

A candid interview with diaTribe advisory board member Dr. Anne Peters touches on the newest drugs and devices, curing type 1, and addressing obesity.